Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19-Reference-Cited by-同舟云学术

Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19

Published:2020-06 Issue:6 Volume:26 Page:806-810
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Turner Leigh

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference10 articles.

1. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use;Atluri;Pain Physician,2020

2. SCIENTIFIC COMMUNITY. Confronting stem cell hype;Caulfield;Science,2016

3. Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions;Horner;NPJ Regen. Med.,2018

4. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics;Kalil;JAMA,2020

5. Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19;Khoury;Eur. Respir. J.,2020

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical use of autologous cell-based therapies in an evolving regulatory landscape: A survey of patient experiences and perceptions;F1000Research;2024-08-27

2. The evolution and ongoing challenge of unproven cell-based interventions;Stem Cells Translational Medicine;2024-07-23

3. Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims;Stem Cell Reports;2023-11

4. Clinical use of autologous cell-based therapies in an evolving regulatory landscape: A survey of patient experiences and perceptions;F1000Research;2023-09-18

5. The Early Detection of Fraudulent COVID-19 Products From Twitter Chatter: Data Set and Baseline Approach Using Anomaly Detection;JMIR Infodemiology;2023-03-14